Reuters logo
Some pharmaceutical makers may be targets -Barron's
January 30, 2011 / 6:06 PM / in 7 years

Some pharmaceutical makers may be targets -Barron's

NEW YORK, Jan 30 (Reuters) - Major drug makers are looking for products by purchasing smaller companies, creating many value opportunities, Barron’s reported in its Jan. 31 edition.

Among the companies that Barron’s singled out were Acorda (ACOR.O), AMAG Pharmaceuticals (AMAG.O), Alexion (ALXN.O), BioMarin (BMRN.O), Cadence CADX.O, Cephalon CEPH.O, Cubist CBST.O, Dendreon DNDN.O, Human Genome HGSI.O, Jazz Pharma (JAZZ.O), Onyx ONXX.O, United Therapeutics (UTHR.O), and Salix Pharmaceuticals SLXP.O. (Reporting by Caroline Humer; Editing by Marguerita Choy)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below